PTH and hypercalcemia disease: Ten patients with higher rhPTH1-84 doses at baseline (82.8 ± 33 μg/day) had hypocalcemia; 14 patients with lower doses at baseline presented with calcium values indicating hypercalcemia and lower TransCon PTH doses after 1 month.